Cocaine topical solution - Lannett

Drug Profile

Cocaine topical solution - Lannett

Alternative Names: C-Topical; Cocaine hydrochloride solution - Lannett

Latest Information Update: 03 Nov 2016

Price : $50

At a glance

  • Originator Lannett
  • Class Alkaloids; Local anaesthetics; Tropanes
  • Mechanism of Action Adrenergic receptor agonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Anaesthesia

Most Recent Events

  • 27 Oct 2016 Lannett announces intention to submit NDA to the US FDA in 2017
  • 05 Jul 2016 Chemical structure information added
  • 01 Jul 2016 Lannett completes a phase III trial in Anaesthesia in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top